Enter assignee name

Forward Citations = 42

Loading Chart...

5 inventors (with patents filed for the assignee):

Peter David Davis (7 out of 20 patents)

Jean Claude Arnould (2 out of 2 patents)

Jean-Claude Arnould (1 out of 9 patents)

4. Francis Thomas Boyle (1 out of 33 patents)

5. Graeme Dougherty (1 out of 1 patent)

10 patents: Sort by Forward Citations

1. 7875727 - Benzimidazole vascular damaging agents (2011-01-25),

2. 7265136 - Substituted stilbene compounds with vascular damaging activity (2007-09-04),

3. 7135502 - Colchinol derivatives as vascular damaging agents (2006-11-14),

4. 7105501 - Compositions with vascular damaging activity (2006-09-12),

5. 7087627 - Combinations for the treatment of diseases involving angiogenesis (2006-08-08),

6. 7081469 - Benzimidazole vascular damaging agents (2006-07-25),

7. 6846925 - Colchinol derivatives as angiogenesis inhibitors (2005-01-25),

8. 6720323 - Colchinol derivatives as angiogenesis inhibitors (2004-04-13),

9. 6645950 - Benzimidazole vascular damaging agents (2003-11-11),

10. 6423753 - Use of colchinol derivatives as vascular damaging agents (2002-07-23),

Angiogene Pharmaceuticals Limited is a biopharmaceutical company focused on developing innovative therapies for vascular diseases. Our pipeline includes novel treatments for conditions such as peripheral artery disease and diabetic retinopathy. Through our cutting-edge research and strategic partnerships, we aim to improve patient outcomes and make a meaningful impact in the field of vascular medicine.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

10 Patents

#23 in Oxford

#1,698 in United Kingdom

#54,316 in the World

Oxford, United Kingdom

Angiogene Pharmaceuticals Limited